Baird Medical Investment (BDMD) Competitors $2.33 -0.09 (-3.72%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BDMD vs. DRTS, CLPT, NPCE, TCMD, SMTI, SNWV, BWAY, SKIN, SI, and OMShould you be buying Baird Medical Investment stock or one of its competitors? The main competitors of Baird Medical Investment include Alpha Tau Medical (DRTS), ClearPoint Neuro (CLPT), NeuroPace (NPCE), Tactile Systems Technology (TCMD), Sanara MedTech (SMTI), Sanuwave Health (SNWV), Brainsway (BWAY), Beauty Health (SKIN), Shoulder Innovations (SI), and Outset Medical (OM). These companies are all part of the "medical equipment" industry. Baird Medical Investment vs. Its Competitors Alpha Tau Medical ClearPoint Neuro NeuroPace Tactile Systems Technology Sanara MedTech Sanuwave Health Brainsway Beauty Health Shoulder Innovations Outset Medical Alpha Tau Medical (NASDAQ:DRTS) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, media sentiment, valuation, profitability and analyst recommendations. Do insiders and institutionals hold more shares of DRTS or BDMD? 2.7% of Alpha Tau Medical shares are owned by institutional investors. Comparatively, 19.8% of Baird Medical Investment shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by company insiders. Comparatively, 78.9% of Baird Medical Investment shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is DRTS or BDMD more profitable? Baird Medical Investment's return on equity of 0.00% beat Alpha Tau Medical's return on equity.Company Net Margins Return on Equity Return on Assets Alpha Tau MedicalN/A -51.21% -38.18% Baird Medical Investment N/A N/A N/A Which has preferable earnings and valuation, DRTS or BDMD? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlpha Tau MedicalN/AN/A-$31.75M-$0.48-8.67Baird Medical InvestmentN/AN/AN/AN/AN/A Which has more risk and volatility, DRTS or BDMD? Alpha Tau Medical has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.Comparatively, Baird Medical Investment has a beta of -0.97, indicating that its stock price is 197% less volatile than the S&P 500. Does the media refer more to DRTS or BDMD? In the previous week, Alpha Tau Medical and Alpha Tau Medical both had 1 articles in the media. Alpha Tau Medical's average media sentiment score of 1.91 beat Baird Medical Investment's score of 1.89 indicating that Alpha Tau Medical is being referred to more favorably in the media. Company Overall Sentiment Alpha Tau Medical Very Positive Baird Medical Investment Very Positive Do analysts prefer DRTS or BDMD? Alpha Tau Medical currently has a consensus price target of $9.00, suggesting a potential upside of 116.35%. Given Alpha Tau Medical's stronger consensus rating and higher probable upside, equities analysts clearly believe Alpha Tau Medical is more favorable than Baird Medical Investment.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Tau Medical 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Baird Medical Investment 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryAlpha Tau Medical beats Baird Medical Investment on 5 of the 9 factors compared between the two stocks. Get Baird Medical Investment News Delivered to You Automatically Sign up to receive the latest news and ratings for BDMD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BDMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BDMD vs. The Competition Export to ExcelMetricBaird Medical InvestmentMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$83.25M$6.51B$5.65B$10.29BDividend YieldN/A1.20%5.68%4.62%P/E RatioN/A25.0375.8426.11Price / SalesN/A197.54517.46171.25Price / CashN/A21.7937.5661.52Price / BookN/A5.0112.876.30Net IncomeN/A$178.07M$3.29B$271.03M7 Day Performance-9.34%-1.26%-0.26%-0.15%1 Month Performance-2.51%6.15%3.84%6.41%1 Year PerformanceN/A22.81%68.35%28.81% Baird Medical Investment Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BDMDBaird Medical InvestmentN/A$2.33-3.7%N/AN/A$83.25MN/A0.00N/APositive NewsGap DownDRTSAlpha Tau Medical2.3068 of 5 stars$4.12-1.0%$9.00+118.4%+79.6%$349.46MN/A-8.5880CLPTClearPoint Neuro0.8569 of 5 stars$12.16+1.1%$19.67+61.7%+69.1%$345.71M$31.39M-15.01110News CoverageOptions VolumeGap UpNPCENeuroPace3.3326 of 5 stars$10.39+0.3%$16.60+59.8%+44.1%$343.71M$88.57M-12.37170Positive NewsTCMDTactile Systems Technology2.2422 of 5 stars$14.17+0.1%$13.50-4.7%+0.9%$315.85M$292.98M22.851,037News CoveragePositive NewsSMTISanara MedTech2.3866 of 5 stars$33.10-2.2%$50.00+51.1%+10.5%$294.59M$86.67M-28.5360Positive NewsSNWVSanuwave Health2.1592 of 5 stars$34.23-3.0%$55.00+60.7%N/A$293.35M$32.63M-4.1540BWAYBrainsway3.6515 of 5 stars$15.36-1.0%$18.00+17.2%+83.4%$290.61M$41.02M59.08120Positive NewsSKINBeauty Health1.9437 of 5 stars$2.18-4.4%$2.81+29.0%+43.4%$276.48M$310.06M-7.791,030Trending NewsAnalyst ForecastSIShoulder Innovations3.1794 of 5 stars$13.37-5.0%$19.60+46.6%N/A$272.21MN/A-0.4561OMOutset Medical2.1628 of 5 stars$14.85-5.8%$24.67+66.1%+81.6%$263.88M$113.69M-0.73520Positive News Related Companies and Tools Related Companies DRTS Competitors CLPT Competitors NPCE Competitors TCMD Competitors SMTI Competitors SNWV Competitors BWAY Competitors SKIN Competitors SI Competitors OM Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BDMD) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baird Medical Investment Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Baird Medical Investment With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.